Sep 14, 2022 / 03:10PM GMT
Kristine Tan Liwag - Morgan Stanley, Research Division - Equity Analyst
Hey, everyone. Thanks for joining our next session. I'm Kristine Liwag, Head of our Aerospace and Defense Research at Morgan Stanley. So I am pleased to have Kathy Warden, CEO of Northrop Grumman; and Dave Keffer, CFO of Northrop Grumman. So thank you, Kathy and Dave.
Before we get started, set of disclosures. For full disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. I'm sure it's a very exciting website. If you have any questions, please reach out to your Morgan Stanley representative.
And with that, Dave, you've got also disclosures.
David F. Keffer - Northrop Grumman Corporation - Corporate VP & CFO
That's right. Thanks, Kristine.
Good morning, everyone. Today, we're going to make some forward-looking statements, and those statements involve risks and uncertainties. Information about these risks and
Northrop Grumman Corp at Morgan Stanley Laguna Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot